Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome-Reference-Cited by-同舟云学术

Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome

Published:2020-09-18 Issue:2 Volume:109 Page:462-470
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Ruiz‐Pinto Sara¹,Pita Guillermo¹,Martín Miguel²,Nuñez‐Torres Rocío¹,Cuadrado Ana³,Shahbazi Marta N.⁴⁵,Caronia Daniela¹,Kojic Alexander³,Moreno Leticia T.¹,Torre‐Montero Julio C.⁶⁷,Lozano María⁸,López‐Fernández Luis A.⁹,Ribelles Nuria¹⁰,García‐Saenz Jose A.⁷,Alba Emilio¹⁰,Milne Roger L.¹¹¹²,Losada Ana³,Pérez‐Moreno Mirna⁴,Benítez Javier¹³,González‐Neira Anna¹

Affiliation:

1. Human Genotyping Unit–Centro Nacional de Genotipado (CEGEN) Human Cancer Genetics Programme Spanish National Cancer Research Centre (CNIO) Madrid Spain

2. Instituto de Investigación Sanitaria Gregorio Marañón Universidad Complutense Madrid Spain

3. Chromosome Dynamics Group. Molecular Oncology Programme Spanish National Cancer Research Centre (CNIO) Madrid Spain

4. Epithelial Cell Biology Group Cancer Cell Biology Programme Spanish National Cancer Research Centre (CNIO) Madrid Spain

5. Department of Physiology Development and Neuroscience University of Cambridge Cambridge UK

6. San Juan de Dios School of Nursing and Physical Therapy Comillas Pontifical University Madrid Spain

7. Medical Oncology Service Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC) Hospital Clínico San Carlos Madrid Spain

8. Laboratory and Research Divison Taper, Madrid Spain

9. Pharmacy Department Laboratory of Pharmacogenomics Instituto de Investigación Sanitaria Gregorio Marañón Hospital General Universitario Gregorio Marañón Madrid Spain

10. UGC Oncología Intercentros Institute of Biomedical Research in Malaga (IBIMA) Hospitales Universitarios Regional y Virgen de la Victoria de Málaga Malaga Spain

11. Cancer Epidemiology & Intelligence Division Cancer Council Victoria Melbourne Victoria Australia

12. Centre for Epidemiology and Biostatistics Melbourne School of Population and Global Health The University of Melbourne Melbourne Victoria Australia

13. Human Genetics Group Human Cancer Genetics Programme Spanish National Cancer Research Centre (CNIO) Madrid Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2013

Reference34 articles.

1. Capecitabine: effective oral fluoropyrimidine chemotherapy

2. Capecitabine and hand–foot syndrome

3. Safety of capecitabine: a review

4. First‐line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5‐fluorouracil/leucovorin;Cassidy J.;Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.,2002

5. Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical interventions for preventing hand-foot syndrome resulting from antineoplastic therapy: A scoping review;Revista da Escola de Enfermagem da USP;2023

2. Intervenções tópicas para prevenção de síndrome mão-pé decorrente de terapia antineoplásica: revisão de escopo;Revista da Escola de Enfermagem da USP;2023

3. Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX);Nutrients;2022-10-22

4. Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib;World Journal of Hepatology;2022-07-27

5. Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (DPYD) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study;Pharmaceutics;2021-11-29